ES2183841T3 - Formas de dosificacion para administrar un farmasco en una formulacion lquidid. - Google Patents

Formas de dosificacion para administrar un farmasco en una formulacion lquidid.

Info

Publication number
ES2183841T3
ES2183841T3 ES94920203T ES94920203T ES2183841T3 ES 2183841 T3 ES2183841 T3 ES 2183841T3 ES 94920203 T ES94920203 T ES 94920203T ES 94920203 T ES94920203 T ES 94920203T ES 2183841 T3 ES2183841 T3 ES 2183841T3
Authority
ES
Spain
Prior art keywords
lquidid
farmasco
administer
formulation
dosage forms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94920203T
Other languages
English (en)
Inventor
Steven D Larsen
George V Guittard
Patrick S-L Wong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of ES2183841T3 publication Critical patent/ES2183841T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE MUESTRA UNA FORMA DE DOSIFICACION (10) PARA ENVIAR MEDICACION (22) EN UN VEHICULO NO ACUOSO A UN ENTORNO BIOLOGICO DE USO.
ES94920203T 1994-06-13 1994-06-13 Formas de dosificacion para administrar un farmasco en una formulacion lquidid. Expired - Lifetime ES2183841T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1994/006723 WO1995034285A1 (en) 1994-06-13 1994-06-13 Dosage form for administering drug in liquid formulation

Publications (1)

Publication Number Publication Date
ES2183841T3 true ES2183841T3 (es) 2003-04-01

Family

ID=22242671

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94920203T Expired - Lifetime ES2183841T3 (es) 1994-06-13 1994-06-13 Formas de dosificacion para administrar un farmasco en una formulacion lquidid.

Country Status (11)

Country Link
EP (1) EP0768867B1 (es)
JP (1) JP3901727B2 (es)
KR (1) KR100360636B1 (es)
AT (1) ATE225647T1 (es)
AU (1) AU682703B2 (es)
CA (1) CA2185119C (es)
DE (1) DE69431533T2 (es)
DK (1) DK0768867T3 (es)
ES (1) ES2183841T3 (es)
PT (1) PT768867E (es)
WO (1) WO1995034285A1 (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5904935A (en) * 1995-06-07 1999-05-18 Alza Corporation Peptide/protein suspending formulations
JP2001520170A (ja) 1997-10-16 2001-10-30 ボード・オヴ・リージェンツ，ザ・ユニヴァーシティ・オヴ・テキサス・システム Ｎｆ−ａｔ３機能に関連した心肥大動物モデルと治療法
DE69928815T2 (de) * 1998-09-09 2006-06-29 Alza Corp., Mountain View Dosierungsform mit flüssiger formulierung
DE69915346T2 (de) * 1998-12-17 2004-07-22 Alza Corp., Mountain View Umwandlung von flüssigkeitsgefüllten gelatinkapseln in systeme mit gesteuerter wirkstoffabgabe durch mehrfache beschichtungen
US7258869B1 (en) 1999-02-08 2007-08-21 Alza Corporation Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
US7919109B2 (en) 1999-02-08 2011-04-05 Intarcia Therapeutics, Inc. Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
KR20050083874A (ko) * 2002-10-31 2005-08-26 알자 코포레이션 액상 제제의 방출을 증진시키는 제형
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
WO2005072079A2 (en) 2003-09-26 2005-08-11 Alza Coporation Drug coating providing high drug loading and methods for providing the same
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
AU2007266475B2 (en) 2006-05-30 2009-12-03 Intarcia Therapeutics, Inc. Two-piece, internal-channel osmotic delivery system flow modulator
AU2007284759B2 (en) 2006-08-09 2010-10-28 Intarcia Therapeutics, Inc. Osmotic delivery systems and piston assemblies
CN105688191A (zh) 2007-04-23 2016-06-22 精达制药公司 促胰岛素释放肽的混悬制剂及其应用
CA2691531C (en) 2007-06-22 2016-11-01 Board Of Regents,The University Of Texas System Formation of stable submicron peptide or protein particles by thin film freezing
DK2240155T3 (da) 2008-02-13 2012-09-17 Intarcia Therapeutics Inc Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler
CA2743789C (en) 2008-11-16 2017-10-31 Board Of Regents, The Univesity Of Texas System Low viscosity highly concentrated suspensions
MX352878B (es) 2009-09-28 2017-12-13 Intarcia Therapeutics Inc Establecimiento y/o terminacion rapidos de suministro de estado estable sustancial de farmaco.
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
TWI615155B (zh) * 2011-11-01 2018-02-21 拜耳股份有限公司 滲透活性的陰道遞送系統
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
CN113598842A (zh) 2015-06-03 2021-11-05 因塔西亚制药公司 植入物放置和移除系统
MX2018014016A (es) 2016-05-16 2019-08-01 Intarcia Therapeutics Inc Polipéptidos selectivos del receptor de glucagón y métodos para utilizarlos.
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
EP3565580B1 (en) 2017-01-03 2024-03-06 i2o Therapeutics, Inc. Continuous administration of exenatide and co-adminstration of acetaminophen, ethinylestradiol or levonorgestrel
ES2909803T3 (es) 2018-03-05 2022-05-10 Amneal Complex Products Res Llc Composiciones farmacéuticas programables para la cronoliberación de fármacos
USD933219S1 (en) 2018-07-13 2021-10-12 Intarcia Therapeutics, Inc. Implant removal tool and assembly
WO2020181127A1 (en) 2019-03-05 2020-09-10 Kashiv Biosciences, Llc Delayed release methylphenidate compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2155889B (en) * 1984-03-21 1988-03-02 Alza Corp Dispenser-capsule
US4814180A (en) * 1984-03-21 1989-03-21 Alza Corporation Agent dispenser comprising a semipermeable wall surrounding single-piece or two-piece container
US5324280A (en) * 1990-04-02 1994-06-28 Alza Corporation Osmotic dosage system for delivering a formulation comprising liquid carrier and drug

Also Published As

Publication number Publication date
CA2185119C (en) 2005-07-26
DE69431533T2 (de) 2003-10-02
AU682703B2 (en) 1997-10-16
ATE225647T1 (de) 2002-10-15
CA2185119A1 (en) 1995-12-21
PT768867E (pt) 2003-01-31
DE69431533D1 (de) 2002-11-14
KR100360636B1 (ko) 2002-12-18
EP0768867B1 (en) 2002-10-09
KR970703752A (ko) 1997-08-09
WO1995034285A1 (en) 1995-12-21
EP0768867A1 (en) 1997-04-23
JPH10501261A (ja) 1998-02-03
JP3901727B2 (ja) 2007-04-04
AU7108094A (en) 1996-01-05
DK0768867T3 (da) 2002-10-28

Similar Documents

Publication Publication Date Title
ES2183841T3 (es) Formas de dosificacion para administrar un farmasco en una formulacion lquidid.
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
AR240399A1 (es) Dispositivo suministrador para administrar una formulacion de agente beneficioso a un ambiente de uso.
MX171191B (es) Composiciones farmaceuticas de glipizida
ES2165997T3 (es) Uso de una formulacion farmaceutica pediatrica que comprende amoxicilina y clavulanato.
MX9204268A (es) Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
HUP0100043A2 (hu) Savérzékeny hatóanyagot tartalmazó új gyógyszerforma
FI955124A (fi) Protonipumppuinhibiittorin sisältävä eläinlääkeseos
DE19375061I2 (de) Hexadecylphosphocolin enthaltende arzneimittel mit antitumorwirkung.
PT814796E (pt) Uso de um farmaco r-aine numa composicao protectora para o tratamento do cancro colorectal
ES2141208T3 (es) Utilizacion de una cantidad eficaz de sustancias activas para el tratamiento de pieles mixtas.
DE60019334D1 (de) Antivirale arznei
DK1112060T3 (da) Doseringsform anvendende flydende formulering
ITMI913170A1 (it) Composizione farmaceutica per uso oftalmico contenente un antiinfiammatorio non steroideo ed un decongestionante come principi attivi
ES2160821T3 (es) Uso de una composicion que comprende amoxicilina y acido clavulanico para la produccion de un medicamento para el tratamiento de infecciones bacterianas en pacientes pediatricos.
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
IT1264857B1 (it) Composizione farmaceutica liquida per uso orale contenente acido 2-(4-isobutilfenil) propionico
RS50298B (sr) Direktno kompresibilna matrica za kontrolisano oslobađanje pojedinačnih dnevnih doza klaritromicina
ES2090712T3 (es) Medicamento agudo que contiene ibuprofeno y su uso.
IT1264856B1 (it) Composizione farmaceutica ad attivita' analgesica
AR016683A1 (es) Composicion de suministro de droga solida, anhidra, proceso y uso de una pluralidad de particulas inorganicas porosas compuestas de hidroxipatita ceramicapara su preparacion.
YU36401A (sh) Farmaceutska kompozicija za stimulator osetljivosti na insulin sa modifikovanim ispuštanjem
ATE38151T1 (de) Bestaendige 5-adenosyl-l-methionin-salze enthaltende, pharmazeutische zusammensetzungen fuer orale anwendung.
ES2105605T3 (es) Antagonistas de taquiquinina, su preparacion y utilizacion en formulaciones farmaceuticas.
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.